Ophthalmic treatment device, system, and method of use
US11135090B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Sep 11, 2018 |
| Grant date | Oct 5, 2021 |
| Priority date | — |
| Expiry date | Feb 20, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N2005/0667
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Ophthalmic treatment systems and methods of using the systems are disclosed. The ophthalmic treatment systems include (a) a light source device; (b) at least one optical treatment head operatively coupled to the light source device, comprising a light source array, and providing at least one treatment light; and (c) a light control device, which (i) provides patterned or discontinuous treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye); or (ii) adjusts intensity of part or all of the light source array, providing adjusted intensity treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye). The at least one treatment light promotes corneal and/or scleral collagen cross-linking.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.